Nonbacterial and Noninfectious Cystitis

Nonbacterial and Noninfectious Cystitis

No Results

No Results


Nonbacterial cystitis is a catchall term that encompasses various medical disorders, including infectious and noninfectious cystitis, as well as painful bladder syndrome/interstitial cystitis (PBS/IC). PBS/IC describes a syndrome of pain and genitourinary symptoms (eg, frequency, urgency, pain, dysuria, nocturia) for which no etiology can be found. There are many controversies regarding nonbacterial cystitis, including possible etiologic agents, methods of diagnosis, and treatment, especially for noninfectious causes.

Infectious nonbacterial cystitis includes the following forms of the disease:

Candidal infection of the bladder is shown in the image below.

Noninfectious nonbacterial cystitis includes the following forms of the disease:

General symptoms of cystitis include urgency, frequency, dysuria, and, occasionally, hematuria, dyspareunia, abdominal cramps, and/or bladder pain and spasms. Establishing or excluding a specific diagnosis often requires repeated cultures and various urologic procedures, including cystoscopy with bladder biopsies, various bladder tests, and immune system function examinations. Some conditions, such as carcinoma in situbladder calculi, and urethral foreign bodies, may result in symptoms that mimic those of nonbacterial cystitis.

For patient education information, see the Women’s Health Center, as well as Bladder Control ProblemsBlood in the UrineCystoscopy, and Pain During Intercourse.

The images below demonstrate the anatomy of the female pelvis, the gross anatomy of the bladder, and the muscles of the pelvic floor that may be involved in nonbacterial cystitis.

The pathophysiology of the disorder depends on its etiology.

Advances in understanding the pathophysiology of complex pain syndromes have demonstrated growth of bridging neurons in the dorsal horns of the spinal cord between the type C pain fibers and the type A pain fibers, indicating perception of pain started by stimulus that is usually nonpainful.

Another example of neural cross-talk is an experiment in rats that demonstrated increased muscle spasm in the bladder with colonic irritation and in the colon with bladder irritation. This may help to explain the concomitant occurrences of irritable bowel syndrome, pelvic pain syndrome, and interstitial cystitis. [1]


Cytopathologic viruses, such as herpes simplex virus–1 (HSV-1) and HSV-2, live integrated into the host genome in the nervous system. Impairment of immune surveillance, which can be caused by comorbid diseases, drugs, or chronic activation of the neuroendocrine pathways involved with corticosteroid production, allow the virus to activate, travel down the peripheral nerves, and cause an outbreak of the disease. Viruses normally do not cause cystitis in immunocompetent adults. In a given patient, however, whether the infection is due to primary infection or reactivation of latent virus is unclear.


Chlamydiae are obligate intracellular parasites with a unique reproductive cycle that involves 2 forms: (1) an extracellular form adapted to survival in the environment, which allows the infection to be transmitted from one person to another, and (2) an intracellular form that replicates and produces more extracellular forms. Chlamydia trachomatis is the organism most commonly identified; in addition to cystitis, it can cause the following disorders:


Initial infection with mycobacteria generally elicits a mild inflammatory response with few or no symptoms. Weeks after the primary infection, with continued replication of the bacilli, development of cell-mediated immunity leads to macrophage infiltration and ingestion of the pathogen.

While mycobacteria can persist within macrophages, replication usually ceases, and spread of the disease is contained. Individuals with disturbances in cell-mediated immune responses are therefore at higher risk for dissemination of the infection.

Other infections

Fungal infections can occur in immunocompetent hosts, but they are more likely to occur in individuals with abnormal immune systems. Species of fungi associated with urogenital fungal infections include Blastomyces dermatitidis, Candida species, and Torulopsis glabrata.

Schistosomiasis can cause symptoms of cystitis, including frequency, urgency, and dysuria. Schistosoma eggs are deposited within the bladder wall as part of their life cycle. An eosinophilic immune reaction is generated in response to the eggs, leading to chronic inflammation. Chronic schistosomiasis can eventually result in small bladder capacity, obstructive uropathy, and bladder cancer.

Radiation cystitis is presumably due to the ionizing radiation administered for treatment for pelvic and urogenital cancers. In a study by Perez et al, [2] the volume of space irradiated and the total dose of radiation were important factors that influenced morbidity. Patients treated with stationary radiation portals that delivered higher doses of radiation to the bladder had a significantly higher incidence of morbidity than did patients treated with rotating portals (18% vs 5%, respectively).

Eosinophilic cystitis has been associated with various etiologic factors, such as allergies, bladder tumors, and parasitic infections, which stimulate antigen formation, leading to antigen-antibody complexes that stimulate inflammatory cascades. This, in turn, leads to eosinophil infiltration and chemokine release, causing fibrosis. [3]

Chemical cystitis, which is due to chemotherapy with alkylating agents such as cyclophosphamide, is thought to be due to metabolites excreted in the urine. The effects appear to be related to the dose and duration of therapy.

Viruses normally do not cause cystitis in immunocompetent adults. Improved molecular detection techniques have allowed the recognition of viral infections, such as the following, in immunocompromised patients:

BK polyomavirus infections [4]

Cytomegalovirus (CMV) infections (associated with hemorrhagic cystitis after bone marrow transplantation [5, 6] )

Adenovirus infections [7]

Herpes and chlamydial cystitis are sexually transmitted, while other types, such as fungal cystitis, occur mainly in immunocompromised hosts. [8, 9]  Corynebacterium urealyticum has been associated with a very rare chronic inflammatory disorder, encrusted cystitis, which is characterized by precipitation and encrustation of phosphate ammonium magnesium salts on the bladder mucosa. [10] Yeast infiltration of the bladder is shown in the image below.

Schistosomiasis (shown in the image below) can cause severe cystitis and lower urinary tract symptoms, due to an inflammatory reaction to Schistosoma eggs embedded in the host’s bladder.

Cystitis may occur following radiation therapy to the pelvis for cancer treatment. The average time from the beginning of radiation therapy to initial symptoms can be several months to several years. Symptoms can include anything from mild bleeding to severe, recurrent bleeding and pain requiring hospitalization for treatment.

Autoimmune diseases such as systemic lupus erythematosus (SLE) or Sjögren syndrome can also be associated with irritative bladder symptoms, such as frequency or pain. Eosinophilic cystitis is a rare pathologic condition characterized by transmural inflammation of the bladder predominantly by eosinophils and fibrosis, with or without muscle necrosis. [3]

Cystitis may also be caused by chemicals and medications. Cyclophosphamide, used to treat malignancies and vasculitides (eg, SLE, granulomatosis with polyangiitis [Wegener granulomatosis]) can cause hemorrhagic cystitis. [11] Low-dose methotrexate, used to treat rheumatoid arthritis, has also been reported to cause hemorrhagic cystitis. [12]

Reports have documented cystitis arising after the recreational abuse of ketamine, an anesthetic agent. [13]  ​ 


The frequency of viral and herpetic cystitis is unclear because culture results can be falsely negative. For example, it has been proposed that both HSV-1 and HSV-2 may initially cause asymptomatic infections, so the incidence of herpetic cystitis may be higher than culture-positive results indicate.

Hemorrhagic cystitis (HC) due to adenoviral infections is common in immunocompromised hosts, especially bone marrow transplant recipients or those with acquired immunodeficiency syndrome (AIDS). Hemorrhagic cystitis due to infection with adenoviruses or BK polyomavirus has been reported in 20% and 8% of pediatric bone marrow transplant patients, respectively.

The frequency of BKV-associated HC in hematopoietic stem cell transplant (HSCT) recipients is about 10%. [4]

The frequency of chlamydial genitourinary infections may also be higher than cultures indicate. A study of 130 patients aged 14-25 years in an urban outpatient clinic demonstrated a 21% frequency of C trachomatis infection; one third were asymptomatic. Risk factors for Chlamydia infection in this group included younger age, more than one sexual partner, and international travel. In another study, of 36 cases of bladder biopsies performed to evaluate cystitis, antigen from C trachomatis was detected by immunochemistry in one third of the specimens.

Mycobacterial cystitis or urogenital tuberculosis is more common in underdeveloped countries and continues to be a major urologic problem in places such as North Africa, mainly because of diagnosis delays. The tuberculosis vaccine, bacillus Calmette-Guérin (BCG), which may be instilled into the bladder to treat bladder tumors, has also been reported to cause cystitis.

Fungal cystitis, most commonly due to Candida species, [14] is more common in immunocompromised hosts, such as those with diabetes mellitus, those who have received chemotherapy, older subjects, women, and those with indwelling catheters who have received multiple courses of antibiotics.

Candida represented 55% of pathogens responsible for ICU-acquired positive urine cultures in a study of 406 ICU patients. Illness severity was identified as a risk factor for candiduria in the study population. [15]

Schistosomiasis most frequently occurs in the developing world, although it is estimated that 400,000 cases exist in the United States. There are five different species of schistosomes; Schistosoma haematobium often causes urinary tract infections. [16]

Radiation cystitis was reported to occur in 6.5% of 1784 patients treated with a combination of external beam and intracavitary radiotherapy for stage Ib carcinoma of the cervix. Perez et al reported moderate-to-severe cystitis occurring in 12% of 738 patients treated with definitive irradiation therapy for prostate cancer after 10 years. [2]

Autoimmune disease related to cystitis is another entity that may be more common than previously realized. A review in Sweden demonstrated that 17% of all patients diagnosed with interstitial cystitis had rheumatoid arthritis, 47% had hypersensitivity reactions or allergies, and 2.3% had either ulcerative colitis or Crohn disease, a rate more than 30 times the prevalence rate in the general population.

Both Sjögren syndrome and SLE have been associated with urinary symptoms. In one study by Haarala et al of 121 patients and 121 age- and sex-matched controls, more than 60% of patients had some urinary symptoms, compared with 20% of controls. [17]

Approximately 30% of long-term ketamine abusers experience ketamine-induced cystitis (KC). The incidenc of KC has risen in recent years in Taiwan, Hong Kong, Singapore, Malaysia, and in some European countries. However, the actual prevalence of KC is unknown. [18]  

Infectious causes of nonbacterial cystitis, such as HSV-1 or HSV-2, can be treated; however, the treatment does not eliminate the dormant virus integrated into the host genome, so the disease can recur.

Both chlamydial and mycobacterial infections can be cured. For chlamydial disease, cure is not protective and the disease can be reacquired. In addition, while mycobacterial infections can generally be cured with regimens containing 3 or 4 drugs, a review by Mnif et al of 60 cases of urogenital tuberculosis found that only 2 were cured by medical therapy alone. [19]  Of the remaining patients, 54 required one of the following surgical interventions:

Two patients whose medical status and nutritional status were poor to begin with died despite aggressive therapy.

Fungal infections are usually curable, depending on the underlying health status of the patient. Because patients with severe immunosuppression (eg, those with untreatable malignancies, AIDS, poorly controlled diabetes, transplant recipients) are the ones most likely to develop these infections, some patients may require continued treatment to ensure that the infection does not recur.

Radiation cystitis, when it does occur, is usually mild and does not require specific therapy. [20] However, the incidence of bleeding, scarring, and/or obstruction increases over time, and symptoms may occur for the first time many years after the radiation treatment. Some patients with heavy bleeding, strictures, or obstruction may require urinary diversion surgery for symptom relief. [21]

Chemical cystitis due to chemotherapy agents is generally mild, with no long-term consequences, and resolves when the medications are stopped. No known cures exist for autoimmune disease–associated cystitis, but symptoms can often be controlled with anti-inflammatory agents or corticosteroids. Eosinophilic cystitis often recurs despite resection of the lesion and anti-inflammatory treatments, so long-term follow-up is required. [3]

Ketamine-induced cystitis improves in most patients after cessation of ketamine use. Recurrent UTI and symptom relapse occur in patients who reuse ketamine after treatment. Patients who continue to abuse ketamine or with longer duration of ketamine abuse may develop intractable bladder pain that is refractory to treatment. Patients with chronic vesicoureteral reflux and/or hydronephrosis may develop irreversible renal function impairment. [18]  

Pezzone MA, Liang R, Fraser MO. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005 Jun. 128(7):1953-64. [Medline].

Perez CA, Lee HK, Georgiou A, Lockett MA. Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1994 Mar 1. 28(4):811-9. [Medline].

Teegavarapu PS, Sahai A, Chandra A, Dasgupta P, Khan MS. Eosinophilic cystitis and its management. Int J Clin Pract. 2005 Mar. 59(3):356-60. [Medline].

Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies. Clin Microbiol Rev. 2017 Apr. 30 (2):503-528. [Medline]. [Full Text].

Boeckh M, Erard V, Zerr D, Englund J. Emerging viral infections after hematopoietic cell transplantation. Pediatr Transplant. 2005 Dec. 9 Suppl 7:48-54. [Medline].

Fioriti D, Degener AM, Mischitelli M, Videtta M, Arancio A, Sica S, et al. BKV infection and hemorrhagic cystitis after allogeneic bone marrow transplant. Int J Immunopathol Pharmacol. 2005 Apr-Jun. 18(2):309-16. [Medline].

Carrigan DR. Adenovirus infections in immunocompromised patients. Am J Med. 1997 Mar 17. 102(3A):71-4. [Medline].

Bavastrelli M, Midulla M, Rossi D, Salzano M, Calzolari E, Midulla C, et al. Sexually active adolescents and young adults: a high-risk group for Chlamydia trachomatis infection. J Travel Med. 1998 Jun. 5(2):57-60. [Medline].

Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000 Mar 23. 342(12):844-50. [Medline].

Pierciaccante A, Pompeo ME, Fabi F, Venditti M. Successful treatment of Corynebacterium urealyticum encrusted cystitis: a case report and literature review. Infez Med. 2007 Mar. 15(1):56-8. [Medline].

Martin-Suarez I, D’Cruz D, Mansoor M, Fernandes AP, Khamashta MA, Hughes GR. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis. 1997 Aug. 56(8):481-7. [Medline]. [Full Text].

Kawabe Y, Eguchi K, Tsuboi M, Kita M, Tsukada T, Takashima H, et al. [Untoward effects of low dose methotrexate therapy in rheumatoid arthritis]. Ryumachi. 1996 Jun. 36(3):514-21. [Medline].

Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome?. BJU Int. 2008 Dec. 102(11):1616-22. [Medline].

Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am. 2014 Mar. 28(1):61-74. [Medline].

Aubron C, Suzuki S, Glassford NJ, Garcia-Alvarez M, Howden BP, Bellomo R. The epidemiology of bacteriuria and candiduria in critically ill patients. Epidemiol Infect. 2015 Feb. 143 (3):653-62. [Medline].

Barsoum RS. Schistosomiasis and the kidney. Semin Nephrol. 2003 Jan. 23(1):34-41. [Medline].

Haarala M, Alanen A, Hietarinta M, Kiilholma P. Lower urinary tract symptoms in patients with Sjögren’s syndrome and systemic lupus erythematosus. Int Urogynecol J Pelvic Floor Dysfunct. 2000. 11(2):84-6. [Medline].

Lee YK, Jhang JF, Kuo HC. Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis. Pain Physician. 2017 Mar. 20 (3):E431-E436. [Medline]. [Full Text].

Mnif A, Loussaief H, Ben Hassine L, Chebil M, Ayed M. [Aspects of evolving urogenital tuberculosis. 60 cases]. Ann Urol (Paris). 1998. 32(5):283-9. [Medline].

Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, et al. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 1998 May 1. 41(2):257-62. [Medline].

Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov. 55(2):206-10. [Medline].

Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, et al. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013 May. 63(5):953-9. [Medline].

Shurbaji MS, Dumler JS, Gage WR, Pettis GL, Gupta PK, Kuhadja FP. Immunohistochemical detection of chlamydial antigens in association with cystitis. Am J Clin Pathol. 1990 Mar. 93(3):363-6. [Medline].

Moussa OM, Eraky I, El-Far MA, Osman HG, Ghoneim MA. Rapid diagnosis of genitourinary tuberculosis by polymerase chain reaction and non-radioactive DNA hybridization. J Urol. 2000 Aug. 164(2):584-8. [Medline].

Etienne M, Caron F. [Management of fungal urinary tract infections]. Presse Med. 2007 Dec. 36(12 Pt 3):1899-906. [Medline].

Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol. 1995 Nov. 33(11):2913-9. [Medline]. [Full Text].

Min JK, Byun JY, Lee SH, Hong YS, Park SH, Cho CS, et al. Urinary bladder involvement in patients with systemic lupus erythematosus: with review of the literature. Korean J Intern Med. 2000 Jan. 15(1):42-50. [Medline].

De Vinci C, Pizza G, Cuzzocrea D, Menniti D, Aiello E, Maver P, et al. Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): a preliminary report. Biotherapy. 1996. 9(1-3):133-8. [Medline].

Egli A, Binggeli S, Bodaghi S, Dumoulin A, Funk GA, Khanna N, et al. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant. 2007 Sep. 22 Suppl 8:viii72-viii82. [Medline].

Xu HG, Fang JP, Huang SL, Zhou DH, Chen C, Huang K, et al. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation]. Zhonghua Er Ke Za Zhi. 2006 Feb. 44(2):126-30. [Medline].

Philippe M, Ranchon F, Gilis L, Schwiertz V, Vantard N, Ader F, et al. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Apr. 22 (4):723-30. [Medline].

Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2017 Nov 1. 35 (31):3547-3557. [Medline]. [Full Text].

Mott KE, Dixon H, Osei-Tutu E, England EC, Davis A. Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis. Am J Trop Med Hyg. 1985 Nov. 34(6):1119-26. [Medline].

Sommariva ML, Sandri SD, Ceriani V. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol. 2010 Jun. 62(2):145-50. [Medline].

Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther Adv Urol. 2011 Oct. 3(5):223-32. [Medline]. [Full Text].

Allen S, Kilian C, Phelps J, et al. The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Support Care Cancer. 2012 Jan 14. [Medline].

Del Pizzo JJ, Chew BH, Jacobs SC, Sklar GN. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term followup. J Urol. 1998 Sep. 160(3 Pt 1):731-3. [Medline].

Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology. 2005 Apr. 65(4):649-53. [Medline].

Srisupundit S, Kraiphibul P, Sangruchi S, Linasmita V, Chingskol K, Veerasarn V. The efficacy of chemically-stabilized chlorite-matrix (TCDO) in the management of late postradiation cystitis. J Med Assoc Thai. 1999 Aug. 82(8):798-802. [Medline].

Ballen KK, Becker P, Levebvre K, Emmons R, Lee K, Levy W, et al. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology. 1999 Nov. 57(4):287-92. [Medline].

Wu P, Wang Q, Huang Z, Wang J, Wu Q, Lin T. Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment. World J Urol. 2016 Sep. 34 (9):1329-36. [Medline].

Zeng J, Lai H, Zheng D, Zhong L, Huang Z, Wang S, et al. Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. J Int Med Res. 2017 Apr. 45 (2):792-797. [Medline]. [Full Text].

Jhang JF, Birder LA, Chancellor MB, Kuo HC. Patient characteristics for different therapeutic strategies in the management ketamine cystitis. Neurourol Urodyn. 2017 Mar. 36 (3):687-691. [Medline].

Sharma BN, Li R, Bernhoff E, et al. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res. 2011 Oct. 92(1):115-23. [Medline].

Lynda A Frassetto, MD Clinical Professor, Department of Internal Medicine, University of California, San Francisco, School of Medicine

Lynda A Frassetto, MD is a member of the following medical societies: American College of Physicians, American Society of Nephrology

Disclosure: Nothing to disclose.

Benjamin Newell Breyer, MD, MS Assistant Professor, Trauma and Reconstruction, Department of Urology, University of California, San Francisco, School of Medicine

Benjamin Newell Breyer, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Urological Association, Endourological Society

Disclosure: Nothing to disclose.

Edward David Kim, MD, FACS Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, Sexual Medicine Society of North America, Tennessee Medical Association

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Endo, Avadel.

Erik T Goluboff, MD Professor, Department of Urology, College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons; Director of Urology, Allen Pavilion, New York Presbyterian Hospital

Erik T Goluboff, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Urological Association, Medical Society of the State of New York, New York Academy of Medicine, Phi Beta Kappa, and Society for Basic Urologic Research

Disclosure: Nothing to disclose.

Stephen W Leslie, MD, FACS Founder and Medical Director, Lorain Kidney Stone Research Center; Associate Professor of Surgery at Creighton University School of Medicine, Chief of Urology at Creighton University Medical Center

Stephen W Leslie, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, National Kidney Foundation, and Ohio State Medical Association

Disclosure: Nothing to disclose.

Grannum R Sant, MD Residency Program Director, Charles M Whitney Professor and Chairman, Department of Urology, Tufts University School of Medicine

Grannum R Sant, MD is a member of the following medical societies: American Urological Association, International Association for the Study of Pain, Massachusetts Medical Society, Society for Basic Urologic Research, and Society of University Urologists

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Nonbacterial and Noninfectious Cystitis

Research & References of Nonbacterial and Noninfectious Cystitis|A&C Accounting And Tax Services